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Abstract 
Posttraumatic stress disorder (PTSD) is a complex syndrome that occurs following exposure 
to a potentially life threatening traumatic event.  This review summarises the literature on the 
genetics of PTSD including gene-environment interactions (GxE), epigenetics and genetics of 
treatment response. Numerous genes have been shown to be associated with PTSD using 
candidate gene approaches.  Genome-wide association studies have been limited due to the 
large sample size required to reach statistical power.  Studies have shown that GxE 
interactions are important for PTSD susceptibility.  Epigenetics plays an important role in 
PTSD susceptibility and some of the most promising studies show stress and child abuse 
trigger epigenetic changes.  Much of the molecular genetics of PTSD remains to be 
elucidated.  However, it is clear that identifying genetic markers and environmental triggers 
has the potential to advance early PTSD diagnosis and therapeutic interventions and 
ultimately ease the personal and financial burden of this debilitating disorder.   
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1. Introduction 
According to the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders 
(DSM-5)(American, 2013) posttraumatic stress disorder (PTSD) is no longer classified as an 
anxiety disorder but is categorised in disorders relating to traumatic and stressful events 
(Friedman MJ, 2013).  Some of the symptoms of PTSD are characteristic but there are some 
that overlap with other psychiatric disorders (Schnurr, 2013).  The trauma can cause 
significant changes in the hypothalamic pituitary adrenal axis (HPA)(Yehuda, 2001) 
determining future responses to stress.  PTSD can lead to profound social dysfunction as 
memories from the traumatic event can result in fear responses that mimic the original 
exposure.  Those with PTSD can experience sleep difficulties, are easily frightened and have 
concentration and memory problems (Brunello et al., 2001).  As a result sufferers may 
experience relationship challenges, substance misuse and experience feelings of isolation, 
hopelessness and anger.  PTSD can result from a variety of traumatic events including 
military combat, violet assaults, physical and sexual abuse, terrorist encounters, natural 
disasters and serious accidents.  Females are twice as likely to develop PTSD compared to 
males (Breslau, 2009; Kessler et al., 1995).  However, most individuals that are exposed to a 
life threatening experience will not develop PTSD (Breslau, 2009) and this is largely thought 
to be determined by genetics.  This review will focus on epigenetics and the genetic and 
environmental risk factors of PTSD as well as the genetics of treatment response.   
2. Heritability of PTSD  
Twin studies of Vietnam veterans have confirmed that genetic vulnerability is associated with 
PTSD (Koenen et al., 2002; Lyons et al., 1993; True et al., 1993).  Approximately 30% of the 
variance in liability for PTSD symptoms (including re-experiencing, avoidance and hyper-
arousal) was found to be genetic after analysing phenotypes of monozygotic and dizygotic 
twins (Koenen et al., 2002; Lyons et al., 1993; True et al., 1993).  A recent twin study 
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suggests that heritable influences account for 46% of the variance in PTSD (Sartor et al., 
2012) but this could be as high as 71% in females (Sartor et al., 2011).   
Full pedigrees for PTSD have not been collected as genetic vulnerability to PTSD can only 
be assessed if a traumatic experience has occurred.  However, some studies of family history 
have shed light on familial susceptibility to PTSD.  One of the first was a study of World War 
One veterans with “psycho-neurosis” who were compared with controls that had a physical 
injury as a result of war.  None of the controls reported a family history of “psychoneurosis” 
compared to 75% of the cases (Wolfsohn, 1918).   
3. Genetic Risk and Signalling Pathways  
There have been numerous genetic association studies examining the role of various genes in 
PTSD and these are summarised in Table 1.  The table lists 68 candidate gene studies 
covering 31 genes that examined association between PTSD or a PTSD-related phenotype 
and numerous polymorphisms.  It also lists six genome wide association studies (GWAS) that 
identified four genes associated with PTSD.  Table 1 list studies that detected association as 
well as those that failed to detect association, although it is likely that many negative studies 
have not been published.  The earliest study in 1991 (Comings et al., 1991) examined the 
rs1800497 single nucleotide polymorphism (SNP), also known as TaqIA.  This SNP was 
originally considered to be in the dopamine D2 receptor (DRD2) gene as it is only 10 
kilobases downstream but it was later discovered that it lies in a tyrosine kinase gene known 
as the ankyrin repeat and kinase domain containing 1 gene ANKK1 (Dubertret et al., 2004).  
However, it has been postulated that the involvement of TaqIA in psychiatric disorders is due 
to its proximity to, and regulatory effect on the DRD2 gene (Swagell et al., 2012).  Between 
1991 and 2004 there was a total of six PTSD association studies, four of which involved the 
TaqIA or other DRD2 SNPs (Table 1).  Since that time there has been increased activity in 
this area, particularly in the last few years.   
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Table 1. Genetic association studies examining association between PTSD or a PTSD-related phenotype. 
Gene  Polymorphism Finding 
Study 
reference 
Trauma  
Case 
numbers 
Control 
numbers 
Controls 
exposed 
Ethnicity 
Candidate Gene Studies  
ANKK1 rs1800497 T associated (Comings et al., 1991) Severe combat 35 314 No USA Eur 
ANKK1 rs1800497 T associated (Comings et al., 1996) Combat 37 19 Yes USA Eur 
ANKK1 
DRD2 
DRD2 
rs1800497 
rs1079597 
rs1800498 
no association 
no association  
no association 
(Gelernter et al., 1999) Combat 52 87 No USA Eur 
ANKK1 rs1800497 T associated (Young et al., 2002) Combat 91 51 No Aus Eur 
ANKK1 
DRD2 
DRD2 
rs1800497 
rs6277 
rs1799732 
no association 
C associated 
no association 
(Voisey et al., 2009) Combat 127 228 NS Aus Eur 
DRD2 rs12364283 G associated (Nelson et al., 2013)a Various 651 1098 NS Aus mixed 
ANKK1 
BDNF 
SLC6A4 
rs1800497/rs6265 
5´-VNTR 
Val/A1 associated 
no association 
(Hemmings et al., 2013) TB exposure 150 NA Yes 
South Africa non-
Eur 
DRD4 VNTR exon3 L-allele associated  (Dragan and Oniszczenko, 
2009) 
Flood 24 83 Yes Poland 
ANKK1 
SLC6A3 
rs1800497 
rs28363170 
no association 
no association 
(Bailey et al., 2010) Spitak earthquake 200 NA Yes Armenia Eur 
SLC6A3 
BDNF 
SLC6A4 
rs28363170  
rs6265 
5´-VNTR 
9 rept associated  
no association 
no association 
(Valente et al., 2011b) Urban violence 65 369 NS Brazil mixed 
SLC6A3 rs28363170 9 rept associated (Segman et al., 2002) Various 102 104 Yes Israel 
SLC6A3 rs28363170 9 rept associated (Drury et al., 2009) Hurricane Katrina 
New Orleans 
88 88 Yes USA AA & other 
SLC6A3 rs28363170 9 rept associated (Chang et al., 2012) Various 62 258 Yes USA AA & other 
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SLC6A3 rs28363170/rs27072 haplotype 
associated 
(Drury et al., 2013)b Various 66 77 Yes USA AA & other 
SLC6A4 5´-VNTR  S-allele associated (Lee et al., 2005) Various 100 197 NS Korean 
SLC6A4 5´-VNTR /rs25531 S+-haplotype 
associated 
(Kilpatrick et al., 2007) 
Hurricane Katrina 
Florida 
19 570 Yes USA mixed 
SLC6A4 5´-VNTR/rs25531 L/A haplotype 
associated 
(Grabe et al., 2009) Various 67 2978 NS German Eur 
SLC6A4 5´-VNTR S-allele associated (Koenen et al., 2009a) Hurricanes Florida 
various 2004 
19 571 Yes USA mixed 
SLC6A4 5´-VNTR S-allele associated (Kolassa et al., 2010a) Rwandan genocide 331 77 Yes Rwandan 
SLC6A4 5´-VNTR /rs25531 S+-haplotype 
associated 
(Wang et al., 2011) Combat 51 48 Yes USA Eur & other 
SLC6A4 5´-VNTR 
Intron2 VNTR 
S-allele associated 
12 rept associated 
(Sayin et al., 2010) 
Physical trauma 
stroke 
29 48 Yes Turkey Eur 
SLC6A4 5´-VNTR L/L associated (Thakur et al., 2009)c Major vehicle 
accidents 
24 17 Yes USA Eur 
SLC6A4 5´-VNTR/rs25531 S+ haplotype 
associated 
(Xie et al., 2009)d 
Various trauma or 
childhood adversity 
229 1023 Yes USA Eur & AA 
SLC6A4 5´-VNTR/rs25531 S+ haplotype 
associated 
(Walsh et al., 2014) Various 205 477 Yes USA AA 
SLC6A4 5´-VNTR/rs25531 S+ haplotype 
associated 
(Wald et al., 2013) Various 487 NA Yes Israel mixed Jews 
SLC6A4 5´-VNTR/rs25531 S+ haplotype 
associated 
(Pietrzak et al., 2013) Hurricane Ike 149 NA Yes USA Eur & other 
SLC6A4 
TPH2 
5´-VNTR/rs25531 
/rs4570625 
S+T+ genotype 
associated  
(Hermann et al., 2012) Fear conditioning 74 NA NA Not specified 
SLC6A4 
THP1 
TPH2 
5´-VNTR 
rs2108977 
rs11178997 
S associated  
T associated 
(Goenjian et al., 2012) Spitak earthquake 200 NA Yes Armenia Eur 
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SLC6A4 
HTR2A 
5´-VNTR /rs25531 
rs6311 
no association  
G associated 
(Mellman et al., 2009) Various 55 63 Yes USA AA & Eur 
HTR2A rs6311 GG associated in 
females 
(Lee et al., 2007) Various 107 161 NS Korean 
ADCYAP1R1 
& ADCYAP1 
rs2267735 
43 Tag-SNPs 
C associated, 
females 
no association 
(Ressler et al., 2011) Various 398 839 Yes USA AA & other 
ADCYAP1R1 rs2267735 C associated, 
females 
(Almli et al., 2013) Various 911 NA Yes USA AA 
ADCYAP1R1 rs2267735 C associated, 
females 
(Uddin et al., 2013a) Various 23 378 Yes USA AA & other 
ADCYAP1R1 rs2267735 C associated, 
females 
(Wang et al., 2013) 
Wenchuan 
earthquake 
146 174 Yes China  
ADCYAP1R1 rs2267735 C associated, 
females 
(Stevens et al., 2014) Various 49 NA Yes USA AA females 
BDNF rs6265 no association (Lee et al., 2006) Various 107 161 NS Korean 
BDNF 
rs6265 
G712A 
C270T 
no association (Zhang et al., 2006) Various 96 250 NS USA Eur 
BDNF rs6265 A associated (Soliman et al., 2010) Fear conditioning 72 NA NA not specified 
BDNF rs6265 A associated (Pivac et al., 2012) Combat 370 206 Yes Croatian 
BDNF rs6265 A associated (Felmingham et al., 2013) Fear conditioning 55 NA NA Aus Eur 
APOE rs7412 
rs429358 
T/T haplotype  
associated 
(Freeman et al., 2005) Combat 54 NA NA USA Eur 
APOE rs7412 
rs429358 
T/T haplotype  
associated 
(Kim et al., 2013) Combat 128 128 Yes Korean 
APOE rs7412 
rs429358 
C/C haplotype  
associated 
(Lyons et al., 2013) Combat 39 131 Yes USA Eur & others 
CNR1 rs806369/rs1049353 haplotypes (Lu et al., 2008) ADHD parents 25 291 NS USA Eur 
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rs1049353 
rs806377 
rs6454674 
associated 
A associated 
no association 
no association 
CNR1 
rs806369 
rs1049353 
rs806377 
rs6454674 
no association (Lu et al., 2008) Not specified 17 292 NS Finland Eur 
CNR1 rs2180619 
rs1049353 
AA associated 
no association 
(Heitland et al., 2012) Fear conditioning 142 NA NA Netherlands 
FKBP5 
rs9296158 
rs3800373 
rs1360780 
rs9470080 
rs992105 
rs737054 
rs1334894 
rs4713916 
A associated  
C associated 
T associated 
T associated 
no association 
no association 
no association 
no association 
(Binder et al., 2008) Various 762 NA- NA USA AA & other 
FKBP5 
rs9296158 
rs3800373 
rs1360780 
rs9470080 
no association 
no association 
no association 
T associated 
(Xie et al., 2010)d Various 343 2084 NS USA Eur & AA 
FKBP5 
COMT 
CHRNA5 
rs9470080 
rs4680 
rs16969968 
T associated  
A associated  
A associated  
(Boscarino et al., 2011) Various 502 NA Yes USA Eur 
COMT rs4680 A associated (Valente et al., 2011a) Urban violence 65 369 NS Brazil mixed 
COMT rs4680 no association (Kolassa et al., 2010b) Rwandan genocide 340 84 Yes Rwandan 
COMT rs4680 A associated (Schulz-Heik et al., 2011) Combat 51 48 Yes USA Eur & other 
PRKCA rs4790904 A associated (de Quervain et al., 2012) Rwandan genocide 134 213 Yes Rwandan 
PRKCA rs4790904 G associated (Liu et al., 2013) Combat 391 570 Yes USA Eur & AA 
ANK3 rs9804190  C associated (Logue et al., 2013b)e Combat & partners 295 196 Yes USA Eur 
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rs1049862 
rs28932171 
rs11599164 
rs17208576 
T associated 
T associated 
G associated 
G associated 
CAT 
rs208679 
rs10836233 
rs2300182 
rs769217 
rs7104301 
rs7949972 
no association (Duan et al., 2014) Various 173 287 NS Han Chinese 
CRHR1 
rs12938031 
rs4792887 
rs173365 
rs17689966 
rs242924 
rs2664008 
rs171441 
rs16940686 
rs242939 
rs242936 
rs7209436 
rs11040 
A associated 
C associated 
no association 
no association 
no association 
no association 
no association 
no association 
no association 
no association 
no association 
no association 
(White et al., 2013) 
Hurricanes Florida 
various 2004 
564 NA Yes USA Eur 
DBH rs1611115 no association (Mustapic et al., 2007) Combat 133 34 Yes Croatian 
DTNBP1 rs9370822. C associated (Voisey et al., 2010) Combat 127 250 NS Aus Eur 
GABRA2 
rs279836 
rs279826 
rs279871 
rs279858 
T associated 
A associated 
A associated 
no association 
(Nelson et al., 2009)f Various 46 213 NS not specified 
KPNA3 rs2273816 no association (Morris et al., 2012) Combat 121 237 NS Aus Eur 
NOS1AP rs386231 A associated (Lawford et al., 2013) Combat 121 237 NS Aus Eur 
NPY rs16139 no association (Lappalainen et al., 2002) Combat 77 202 NS USA Eur 
NR3C1 rs6189 no association (Bachmann et al., 2005) Combat 118 42 Yes Aus Eur 
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Where possible, studies are arranged by gene then chronologically.  Abbreviations: AA, African American; Aus, Australia; Eur, European descent (excluding Hispanic descent for 
USA populations); NA, not applicable; NS, unselected controls. a 1430 SNPs were analysed in 72 candidate genes. b Double heterozygotes excluded from analysis. c Did not achieve 
significance, p = 0.052.  d Cases and controls were recruited from a cohort of cocaine or opioid dependence and non-dependent controls.  e 359 ANK3 SNPs were examined; f Cases 
and controls were recruited from a cohort with nicotine dependence. g This study is listed as a candidate gene study but GWAS data was generated then ‘mined’ for WWC1 Tag-SNP 
data. 
 
rs6190 
rs56149945 
RGS2 rs4606 C associated (Amstadter et al., 2009) Hurricanes Florida 
Various 2004 
273 334 Yes USA Eur & others 
SRD5A2 rs523349 C associated, males (Gillespie et al., 2013) Various 482 961 Yes USA AA & other 
STMN1 rs182455 C associated, 
females 
(Cao et al., 2013) 
Wenchuan 
earthquake 
146 174 Yes China  
WWC1 
rs10038727 
rs4576167 
& 113 tag-SNPs 
G associated 
G associated 
(Wilker et al., 2013)g African Conflicts 212 579 Yes 
Rwandan 
Ugandan 
Genome-Wide Association Studies (GWAS)       
RORA rs8042149 C associated (Logue et al., 2013a) Combat & partners 295 196 Yes USA Eur 
RORA rs8042149 C associated (Amstadter et al., 2013) Florida Hurricanes 551 NA NA USA Eur 
incRNA 
AC068718  
rs10170218 Associated (Guffanti et al., 2013) Various  94 318 NS Various 
intergenic SNP 
TLL1 
TLL1 
rs406001 
rs6812849 
rs7691872 
Associated 
Associated 
Associated 
(Xie et al., 2013) Various  300 1278 NS USA Eur & AA 
NA NA No significant SNPs (Wolf et al., 2014) Combat & partners 293 191 Yes USA Eur 
SLC18A2 rs363276 SNP & haplotype 
associated 
(Solovieff et al., 2014) Various 845 1693 Yes USA Eur women 
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There have been a total of eight studies examining DRD2/TaqIA SNPs (Table 1).  Because of 
the role of dopamine in stress biology, it is not surprising that dopamine-regulating genes 
including DRD2 have been found to be associated with PTSD (Comings et al., 1996; Lawford 
et al., 2003; Voisey et al., 2009) although the case for TaqIA is less convincing.  A pair of 
polymorphisms in the promoter of the serotonin transporter gene (SLC6A4) have also been 
implicated in PTSD risk and produce a low expression allele (Lee et al., 2005).  This 
involved a SCL6A4 variable number of tandem repeats polymorphism (VNTR) in the 
promoter region (referred to in Table 1 as 5´-VNTR) with short (14 repeats) and long (16 
repeats) alleles and a modifying SCL6A4 A/G polymorphism (rs25531).  Only the long repeat 
allele that also contains the rs25531 A allele results in high levels of SCL6A4 expression 
while all short alleles and long alleles combined with the rs25531 G allele result in low levels 
of SCL6A4 expression.  Table 1 lists 17 association studies of the SLC6A4 promoter 
polymorphisms, some of which only examined the 5´-VNTR polymorphism.  The majority of 
these studies detected association with the SLC6A4 polymorphisms (14 studies detected 
association and three did not).  Despite this, a recent meta analysis of 13 studies showed that 
there is no support for a direct effect of SLC6A4 polymorphisms in PTSD (Navarro-Mateu et 
al., 2013). More recently, a non-synonymous polymorphism in brain–derived neurotrophic 
factor (BDNF) was found associated with psychotic symptoms in PTSD (Pivac et al., 2012) 
and fear conditioning (Felmingham et al., 2013; Soliman et al., 2010). 
Identifying genes that modulate the actions of glucocorticoids including stress and cognition 
may identify novel SNPs associated with PTSD.  The NOS1AP gene encodes nitric oxide 
synthase 1 adaptor protein that binds to the signalling molecule, neuronal nitric oxide 
synthase (nNOS).  Nitric oxide (NO) is produced from its precursor L-arginine by the 
enzyme NO synthase (NOS) which includes at least three distinct isoforms - neuronal 
(nNOS), endothelial, and inducible NOS.  Studies have found that NO release is involved in 
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the activation of glutamate N-methyl-D-aspartate (NMDA) receptors (Southam and 
Garthwaite, 1993).  NOS1AP competes with postsynaptic density protein-95 (PSD-95) for 
nNOS binding and is thought to reduce NMDA receptor signalling via PSD-95 and nNOS.  
An earlier study that identified NOS1AP found that overexpression of NOS1AP results in a 
loss of PSD95/nNOS complexes in transfected cells (Jaffrey et al., 1998).  The NO cascade 
has also been shown to be responsible for hippocampal shrinkage.  Cognitive defects evident 
from PTSD are thought to be the result of hippocampal degeneration (Elzinga and Bremner, 
2002).  During stress, glutamate is released via increased sensitivity of hippocampal 
glucocorticoid receptors which in turn increase the risk of hippocampus atrophy (Sapolsky, 
2001).  Rat studies have found stress mediated glucocorticoid release activated NOS activity 
which subsequently down-regulated hippocampal NMDA receptors and total gamma-
aminobutyric acid (GABA) levels (Harvey et al., 2004).  A partial agonist of the NMDA 
receptor, D-cycloserine, has proved successful in the treatment of PTSD (Heresco-Levy et al., 
2002).   
A SNP, rs386261, in NOS1AP has recently been found associated with PTSD in Vietnam 
War veterans (Lawford et al., 2013).  The study also found that the GG genotype was 
associated with increased severity of depression in patients with PTSD which may increase 
suicide risk and indicate a comorbid phenotype.  This study and many of the studies listed in 
Table 1 should be viewed with caution until they have been replicated, as they are the first 
reports of association in the genes studied.  Although PTSD is seen as an anxiety disorder, it 
is frequently comorbid with depression and studies have identified genes common to both 
(Koenen et al., 2008; Lawford et al., 2006).  As much as 58% of the genetic variance in 
PTSD could be attributed to heritable influences shared with major depressive disorder 
(Koenen et al., 2008).  A study of Vietnam veterans also found that PTSD risk was higher in 
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individuals that had a family history of depression (True et al., 1993) suggesting that PTSD 
and depression share common genetic liability.   
Table 1 highlights some of the difficulties faced when conducting genetic association studies 
in PTSD.  Generally speaking the size of the cohorts of PTSD cases and controls is quite 
small and the type of trauma to which many of the PTSD cases were exposed was either 
poorly defined or of a varied nature.  It is well recognised that there is more power to detect 
genetic association when the phenotype of the cases is more severe and more uniform.  It is 
therefore recommended that future studies concentrate on PTSD patients who present with 
profound impairments following exposure to a relatively uniform trauma such as a specific 
natural disaster or a particular military conflict.  
Genome-wide association studies (GWAS) are commonly used to identify genetic 
associations in case/control studies of disease.  There have been several papers describing 
recommendations for PTSD GWAS studies (Cornelis et al., 2010; Koenen et al., 2009c; 
Koenen et al., 2013) but it is only in the past couple of years that GWAS studies have been 
conducted in PTSD (Table 1).  The first study, like most using the GWAS approach, looked 
at a very large number of SNPs (greater than 1.2 million).  However, most GWAS studies 
need to analyse data from a very large number of cases and controls (typically thousands to 
tens of thousands) in order to achieve statistical significance.  This study is limited by 
examining less than 300 cases and less than 200 controls (Logue et al., 2013a).  Despite this 
limitation they detected association with the retinoid-related orphan receptor alpha (RORA) 
locus and PTSD in trauma exposed veterans (Logue et al., 2013a).  RORA has a role in 
protecting brain cells from injury, stress and disease (Logue et al., 2013a) and the association 
with RORA has since been replicated in hurricane exposed adults with traumatic stress 
symptoms (Amstadter et al., 2013).  The number of PTSD cases reported in the six GWAS 
studies listed in Table 1 varied between 94 (Guffanti et al., 2013) and 551 (Amstadter et al., 
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2013) which is far less than the number usually required in GWAS studies due to the 
difficulty achieving significant associations with smaller numbers of cases and controls. The 
second GWAS study was performed in a relatively small female African American 
population (94 PTSD cases and 319 controls) who had been exposed to varying traumatic 
events (Guffanti et al., 2013).  Only one SNP (rs10170218) in a novel RNA gene incRNA 
AC068718.1 reached genome-wide significance.  This SNP association was replicated in a 
female European population (578 PTSD cases and 1963 controls) and found to be marginally 
significant.  Another study performed a GWAS in 300 European Americans and 444 African 
Americans with PTSD (Xie et al., 2013).  Only one SNP, rs406001, in an intergenic region of 
DNA devoid of known genes reached genome wide significance in the European American 
population and no SNPs reached genome significance in the African American sample set.  
Even though no tolloid-like 1 gene (TLL1) SNPs achieved GWAS significance, when six 
TLL1 SNPs were examined in an independent European American sample, two showed 
association with PTSD (Xie et al., 2013).  The TLL1 gene encodes a metalloprotease that is 
essential for the formation of the interventricular septum in mouse heart (Clark et al., 1999).   
It is notable that none of the GWAS studies detected association in any of the genes identified 
in the candidate gene studies (Table 1).  Often there is also no plausible biological link 
between the associated SNP and PTSD, e.g. one study (Xie et al., 2013) found association 
with a SNP in an intergenic region more than 600 kilobases from the nearest gene, named 
COBL, that is the human homologue of a mouse gene known as cordon-bleu.   
 
4. Gene by environment (GxE) interactions  
Gene by environment (GxE) interactions can determine if an individual is more likely to have 
resilience or later develop PTSD as a consequence of traumatic exposure.  Repeated stress 
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during childhood can cause disruptive HPA (hypothalamic-pituitary-adrenal-axis) response to 
future stress (Davidson and McEwen, 2012; Feder et al., 2009).  Child abuse is known to 
increase the risk of PTSD (Brewin et al., 2000; Paolucci et al., 2001).  One of the first studies 
to determine the effects of genetics in response to environmental risk was a longitudinal study 
that tested why stressful events lead to depression in some individuals but not others (Caspi et 
al., 2003).  Caspi et al. identified a polymorphism in the promoter region of the serotonin 
transporter (SLC6A4) gene that moderates the influence of stressful life events and childhood 
maltreatment on depression (Caspi et al., 2003).  This same polymorphism was later found 
associated with PTSD risk in individuals that had a history of childhood adversity (Xie et al., 
2012; Xie et al., 2009). 
Four SNPs of the FKBP5 gene have also been shown to interact with severity of child abuse 
as a predictor of adult PTSD symptoms (Binder et al., 2008).  Importantly, these FKBP5 
SNPs alone were not associated with PTSD indicating a true gene-environment interaction.  
Gamma-aminobutyric acid receptor alpha-2 (GABRA2) variants are also associated with 
increased lifetime PTSD after exposure to childhood trauma (Nelson et al., 2009).   
Other GxE research has utilised data from the 2004 Florida hurricanes.  The first study 
analysed variation in the promoter of the serotonin transporter gene (SLC6A4).  Individuals 
with high hurricane exposure who carried the low expression promoter variant and had low 
social support were 4.5 times more likely to develop PTSD compared to low-risk individuals 
(Kilpatrick et al., 2007).  A second study by the same group examined whether features of the 
social environment (county-level crime rate and unemployment) modified the association of 
the SLC6A4 promoter variant and risk of current PTSD in a sample from the 2004 Florida 
Hurricane Study.  Individuals carrying the low expressing allele were at increased risk for 
PTSD in high stress environment conditions (Koenen et al., 2009a).   
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The third study analysing the Florida hurricane data focused on a gene previously found to be 
associated with anxiety, the regulator of G-protein signalling 2 gene (RGS2).  The rs4606 
polymorphism of RGS2 was associated with increased symptoms of PTSD under high 
hurricane exposure and low social support.  It was also associated with lifetime PTSD 
symptoms under conditions of lifetime exposure to a potentially traumatic event, and low 
social support (Amstadter et al., 2009).   
Although GxE studies have the potential to identify risk and resilience to PTSD as discussed 
in a recent review of GxE interactions in PTSD, previous studies have been limited because 
of the large number of possible candidate genes and environmental variables which are often 
documented by retrospective self-reports (Koenen et al., 2009b).  This review concluded that 
longitudinal studies need to be designed with comprehensive and objective measures of risk 
(Koenen et al., 2009b).   
5. Epigenetics 
The heritability of PTSD is between 30% and 46%  (Koenen et al., 2002; Sartor et al., 2012; 
True et al., 1993), yet the trigger for PTSD is due to environmental effects. The definition of 
epigenetics has changed over time, and now generally refers to the heritable, but modifiable, 
regulation of genetic functions that are not mediated through the DNA sequence, in particular 
DNA methylation and histone modification.  Early epigenetic studies focused on cancer.  
There is a growing body of evidence to suggest epigenetics plays an important role in 
psychiatric disorders as well (McGowan and Szyf, 2010; Toyokawa et al., 2012).   
Stress is one of the major environmental factors that triggers epigenetic change.  There have 
been few whole genome studies in humans demonstrating epigenetic contribution to PTSD 
onset.  Instead there have been focused epigenetic studies looking at methylation in targeted 
genes (eight studies to date) and only four genome-wide methylation studies of PTSD in 
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humans (Mehta et al., 2013; Smith et al., 2011; Uddin et al., 2010; Uddin et al., 2013b).  
Table 2 summarises these studies.  The most recent whole genome methylation array study 
was performed in peripheral blood cells where they identified unique biological 
modifications in adults with PTSD in the presence of exposure to childhood abuse (Mehta et 
al., 2013).  The second study analysed blood samples from 23 PTSD patients who had 
experienced various traumatic events and 77 individuals without PTSD across 14,000 genes 
(Uddin et al., 2010).  Among the genes found to be differentially methylated, there was an 
over-representation of those involved in immune system function which were found to be 
under methylated in PTSD patients.  Using CMV-a as an independent biological marker of 
immune response to infection it was found that this latent herpes virus had significantly 
higher activity in patients with PTSD.  These results suggest that a traumatic event can alter 
immune function by altering methylation levels of immune related genes.  A later study by 
the same group investigated socioeconomic position as a modifier of the association between 
methylation and traumatic stress (Uddin et al., 2013b).  Like their earlier study they identified 
genes pertaining to nervous system function.  The third genome wide methylation study 
analysed global and site-specific methylation across 14,000 genes (Smith et al., 2011).  The 
study involved African-American participants who had a diagnosis of PTSD with (n = 25) or 
without (n = 25) childhood trauma and controls with (n = 26) or without (n = 34) childhood 
trauma.  Global methylation was increased in those with PTSD and five genes implicated in 
inflammation were found to be differentially methylated in PSTD subjects.   
The majority of PTSD methylation studies to date have been limited in that they have 
analysed mixed ethnic groups and used peripheral tissue rather than a functional tissue such 
as brain.  Only one study (Smith et al., 2011) analysed an African-American cohort as a 
defined ethnic group.  All other studies have used mixed ethnic groups in their analysis but 
the majority of samples (>75 %) used in these groups are African-American.  The only 
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studies to use a predominantly Caucasian population were the two studies (Rusiecki et al., 
2013; Rusiecki et al., 2012) that analysed United States military personnel deployed to 
Afghanistan or Iraq.  The majority of individual studies have also collected participants with 
varying trauma types that may influence methylation patterns.   
More recently there have been two focused studies of the glucocorticoid receptor gene 
(NR3C1) that have analysed defined ethnic groups and trauma (Perroud et al., 2014; Yehuda 
et al., 2014a).  These studies have analysed relatively small samples sizes but are more likely 
to produce consistent and reliably results with well defined cohorts.   
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Table 2.  Summary of PTSD epigenetic studies. 
Study Method Genes 
analysed 
Sample Outcomes 
(Uddin et 
al., 2010) 
Illumina Human 
Methylation27 
BeadChip 
Genome-
wide 
23 PTSD, 77controls 
Mixed ethnicity 
Different Trauma Types 
(DTT) 
Genes implicated in immunity 
differentially methylated in 
PTSD 
(Koenen et 
al., 2011) 
Illumina Human 
Methylation27 
BeadChip 
SLC6A4 23 PTSD, 77controls 
Mixed ethnicity 
DTT 
SLC6A4 methylation levels 
modified the effect of the 
number of traumatic events on 
PTSD 
(Ressler et 
al., 2011)  
Illumina Human 
Methylation27 
BeadChip 
PAC1 N=107 
Mixed ethnicity 
DTT 
CpG methylation level of 
PAC1 was associated with 
PTSD diagnosis 
(Smith et 
al., 2011) 
Illumina Human 
Methylation27 
BeadChip 
Genome-
wide 
25 PTSD + childhood 
trauma (ct), 25 PTSD no 
ct,26 controls + ct, 34 
controls no ct 
African-American 
5 genes TPR, CLEC9A, APC5, 
ANXA2 and TLR8 
differentially methylated in 
PTSD  
(Uddin et 
al., 2011) 
Illumina Human 
Methylation27 
BeadChip 
33 genes 
previously 
found 
associated 
with PTSD  
23 PTSD, 77controls 
Mixed ethnicity 
DTT 
 
MAN2C1 methylation levels 
modify cumulative traumatic 
burden on risk of PTSD 
(Chang et 
al., 2012) 
Illumina Human 
Methylation27 
BeadChip 
SLC6A3 16 PTSD, 67 controls. 
Mixed ethnicity 
DTT 
 
3'UTR VNTR of the SLC6A3 
gene s associated with PTSD 
risk and high methylation 
status in the SLC6A3 promoter 
(Rusiecki et 
al., 2012)  
Pyrosequencing LINE-1 and 
Alu 
US military deployed to 
Afghanistan or Iraq. 75 
PTSD, 75 controls 
Mixed ethnicity 
Hypermethylation of LINE-1 
in controls post-deployment 
and of Alu in cases post-
deployment 
(Klengel et 
al., 2013) 
Pyrosequencing FKBP5 30 PTSD with ct, 45 no 
ct and PTSD 
Mixed ethnicity but 
majority (72) African-
American 
FKBP5 DNA demethylation 
mediates gene-childhood 
trauma interactions 
 
(Mehta et 
al., 2013) 
Illumina Human 
Methylation 
450k array 
Genome-
wide 
32 PTSD with ct, 29 
PTSD with no ct, 108 
controls 
Mixed ethnicity 
Childhood maltreatment 
associated with distinct 
epigenetic profiles in PTSD 
 
(Norrholm 
et al., 2013) 
Illumina Human 
Methylation27 
BeadChip 
COMT 98 PTSD 172 controls 
Mixed ethnicity 
DTT 
 
Higher methylation of COMT 
promoter associated with 
impaired fear inhibition 
(Rusiecki et 
al., 2013) 
Pyrosequencing IGF2, H19, 
IL8, IL16, 
IL18 
US military deployed to 
Afghanistan or Iraq. 75 
PTSD, 75 controls 
Mixed ethnicity 
Controls lower methylation 
levels of H19 and IL18 post-
deployment.  Cases increased 
methylation levels of IL18 
post-deployment 
(Uddin et 
al., 2013b) 
Illumina Human 
Methylation27 
BeadChip 
Genome-
wide 
N=100 trauma exposed 
sample with low 
socioeconomic position 
assessed as a modifier.  
Ethnicity mixed but 
predominantly of 
African-American DTT 
genes predominantly related to 
nervous system function 
(Yehuda et Methylation NR3C1, N=16 FKBP5 associated with 
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al., 2013) mapping using 
clones 
FKBP5 Mixed ethnicity 
8 combat veterans 
treated with 
psychotherapy 
(responders0 and with 
PTSD who were non-
responders to 
psychotherapy 
symptom severity.   
(Yehuda et 
al., 2014b) 
Methylation 
mapping using 
clones 
NR3C1 N=122 combat veterans 
Mixed ethnicity 
Lower NR3C1 promoter 
methylation 
(Yehuda et 
al., 2014a) 
Methylation 
mapping using 
clones 
NR3C1 Adult offspring with a 
Holocaust survivor 
parent N=80 and 
participants without 
parental Holocaust 
exposure or PTSD 
NR3C1 promoter methylation 
altered in relation to parental 
PTSD 
(Labonte et 
al., 2014) 
Sequenom 
epityper 
NR3C1 N=30 PTSD N= 16 non-
PTSD 
Mixed ethnicity 
DTT 
 
Lower methylation of NR3C1 
promoter 
(Perroud et 
al., 2014) 
pyrosequencing NR3C1 N= 25 women exposed 
to Tutsi genocide during 
pregnancy and their 
children and N=25 
women pregnant during 
the same period but not 
exposed to genocide and 
their children.   
Tutsi ethnicity 
Exposed mothers and their 
children had higher 
methylation of NR3C1 exon 
IF.   
 
All the above studies were performed in peripheral blood.  Studies are listed chronologically. 
DTT = different trauma types. 
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6. Genetics of Treatment Response 
Fear is one of the most basic human responses that enables us to respond appropriately to 
emotionally or physically threatening situations (Mineka and Oehlberg, 2008).  However, in 
an appropriate fear response it is just as important to extinguish the fear response when the 
‘threat’ is removed (Hofmann, 2008).  The persistence of a fear response is thought to be the 
basis of anxiety disorders such as PTSD (Myers and Davis, 2002).  Drug therapy for PTSD is 
relatively ineffective (Shalev et al., 2012) and there are few pharmaceuticals that have been 
developed specifically for PTSD.  One of the most favoured current treatment strategies is 
cognitive behaviour therapy which is directed to counteracting the fear response by repeated 
exposure to the fear stimulus without its negative consequences (Felmingham et al., 2013; 
Myers and Davis, 2002). 
There have been very few studies looking at the genetics of treatment response in anxiety 
disorders like PTSD.  Consequently, to date, only three candidate genes have emerged; brain 
derived neurotrophic factor (BDNF)(Felmingham et al., 2013), the endogenous human 
cannabinoid receptor 1 (CNR1)(Heitland et al., 2012) and the SCL6A4 promoter polymorphic 
region (Hermann et al., 2012). 
A recent study on of the BDNF Val66Met polymorphism (rs6265) revealed poorer response 
to exposure therapy in the PTSD patients who carried the Met-66 allele of BDNF compared 
with patients who were homozygous for the Val66 allele (Felmingham et al., 2013).  This is 
particularly important, as recent animal and human evidence suggests that BDNF is critical in 
facilitating fear extinction (Felmingham et al., 2013; Soliman et al., 2010) which is a key 
component of exposure therapy.  
Hermann et al. (Hermann et al., 2012) looked at the combined effect of three polymorphisms 
on fear acquisition and extinction.  They studied two SCL6A4 polymorphisms (the 5´-VNTR 
and rs25531) that produce a low expression allele.  They also combined these polymorphisms 
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with another SNP (rs4570625, G/T) in the tryptophan hydroxylase-2 (TPH2) gene that 
appears to influence the rate of 5-HT synthesis in the presynapse.  It was shown that in 
carriers of the SCL6A4 short allele and the TPH2 rs4570625 T allele there was a profound 
effect on the acquisition and extinction of fear. 
Another study looked at the role of two polymorphisms located within the promoter region 
(rs2180619) and the coding region (rs1049353) of the CNR1 gene in the genetics of fear 
extinction (Heitland et al., 2012).  Neither polymorphism affected acquisition and expression 
of conditioned fear.  Carriers of the rs2180619 G allele (GG and GA) displayed robust fear 
extinction but the A allele homozygotes (AA) showed an absence of fear extinction.  No 
effects of rs1049353 genotype were observed regarding fear acquisition and extinction.  This 
study suggested that the cannabinoid receptor 1 is a potential target for treatment by novel 
and existing agonists of the receptor. 
 
7. Conclusions 
Understanding the molecular genetics of PSTD is still in the early stages.  To date, candidate 
gene studies have been the major approach used to identify genetic association with PTSD 
and there have been a small number of very recent GWAS studies of limited sample size.  
Because of the large sample size required for a GWAS study and the limitations of obtaining 
an adequate sample size in a PTSD cohort, the candidate gene approach may prove the most 
useful.  Future epigenetic studies that investigate the impact of environmental factors 
including stress on biological processes are likely to contribute to our understanding of PTSD 
susceptibility.  More evidence suggests that individuals exposed to childhood maltreatment 
are more likely to be susceptible to PTSD as adults.  Identifying when DNA methylation 
changes occur is also important in understanding the origins of PTSD.  If gene-environmental 
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factors can be identified that affect DNA methylation status, then the incidence of PTSD 
could possibly be reduced by targeting the environmental triggers.  Recent technological 
advances, such as the advent of very large genome-wide epigenetics arrays, are likely to yield 
significant advances over the coming years.  A more complete understanding of the 
molecular genetics of PTSD raises the prospect of improved early detection, stress avoidance 
of those at risk and improved treatment strategies, ultimately leading to improved outcomes 
for PTSD sufferers and reduced burden of disease for sufferers, their families and the 
community in general.  
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